Skip to main content
Caplight Logo









PicturaBio

PicturaBio

Private
OxfordHealthcare & Life Scienceshttps://pictura.bio/

Last Round

Seed

Sep 28, 2026

Total Funding Raised

$9.65M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

PicturaBio is a medical technology company that develops a rapid pathogen detection platform using single-molecule fluorescent microscopy and machine learning to identify infectious diseases at the point of care.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Biotechnology, Defense Tech

Business Model

B2G

Customer Profile

Government Contracts, Hardware + Subscription, Usage-Based SaaS, Hardware Sales

AI Layer

Application

Keywords

pathogen detectionpoint-of-care diagnosticsPOC diagnosticsrapid diagnosticsdiagnostic AIinfectious disease diagnosticsfluorescent microscopymedical imaging AImedical devicediagnostic platformbiodefensemilitary diagnosticsuniversal reagenthardware and consumablesveterinary diagnosticsfood safety testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PicturaBio Comparables

Compare PicturaBio with similar companies based on industry and business-model similarity.

PicturaBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ISBRG Corp.
78%
VAir
77%
GenomeKey
70%

PicturaBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 28, 2026
GrantMay 24, 2023
GrantOct 17, 2022
Pre SeedFeb 15, 2022

Key People

Founding team and executive leadership

Tom Amies

Consultant CFO

Executive Team

PicturaBio Investors

Notable investors and investment history

PicturaBio investors
InvestorRounds
Flu LabPre Seed
IQ CapitalPre Seed
Innovate UKGrant
Defence and Security AcceleratorGrant
Science Creates VenturesPre Seed
Ahren Innovation CapitalPre Seed
Innovate UKGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 28, 2026

    $9.1M raised in Seed round.

  • Aug 10, 2026

    Open roles increased to 4, 2.7x the trailing average.

PicturaBio Filings

Explore SEC and related filing metadata, where available.

PicturaBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about PicturaBio's valuation, stock price, and market status.

Is PicturaBio a public or private company?

PicturaBio is a private company.

What is the current stock price of PicturaBio?

PicturaBio is a private company, so its shares have no public market price. Caplight tracks PicturaBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PicturaBio worth (valuation)?

Valuation information for PicturaBio is not publicly available.

Can I buy PicturaBio stock?

PicturaBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PicturaBio's last funding round?

PicturaBio's most recent funding round was Seed on September 28, 2026.

Who are the main investors in PicturaBio?

Key investors in PicturaBio include IQ Capital, Ahren Innovation Capital.

Will PicturaBio IPO soon?

No public IPO plans have been announced for PicturaBio.

How can I track PicturaBio secondary market activity?

Caplight tracks bids, offers, and trades in PicturaBio's shares on secondary markets.

Firmographic Details

HeadquartersOxford
Employee Range17
Year Founded2022
Last FundingSep 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?